Found: 58
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. C1, doi. 10.1111/dom.15661
- By:
- Publication type:
- Article
Correction to 'In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank'.
- Published in:
- 2024
- Publication type:
- Correction Notice
Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium‐glucose cotransporter‐2 inhibitors versus other medications: A systematic review and meta‐analysis of observational cohort studies
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2487, doi. 10.1111/dom.15571
- By:
- Publication type:
- Article
Differential effect of endogenous glucagon‐like peptide‐1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2476, doi. 10.1111/dom.15570
- By:
- Publication type:
- Article
TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2466, doi. 10.1111/dom.15569
- By:
- Publication type:
- Article
Evaluating the global impact of low physical activity on type 2 diabetes: Insights from the global burden of disease 2019 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2456, doi. 10.1111/dom.15568
- By:
- Publication type:
- Article
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2446, doi. 10.1111/dom.15566
- By:
- Publication type:
- Article
Short, frequent, light‐intensity walking activity improves postprandial vascular‐inflammatory biomarkers in people with type 1 diabetes: The SIT‐LESS randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2439, doi. 10.1111/dom.15564
- By:
- Publication type:
- Article
The Obese Taste Bud study: Objectives and study design.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2054, doi. 10.1111/dom.15563
- By:
- Publication type:
- Article
The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2401, doi. 10.1111/dom.15557
- By:
- Publication type:
- Article
The dual GCGR/GLP‐1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2368, doi. 10.1111/dom.15551
- By:
- Publication type:
- Article
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
- By:
- Publication type:
- Article
The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2046, doi. 10.1111/dom.15559
- By:
- Publication type:
- Article
Personalizing cardiovascular risk: Coronary artery calcium scans to improve statin use in adults with type 2 diabetes can be cost‐effective in select individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2517, doi. 10.1111/dom.15558
- By:
- Publication type:
- Article
During an 18‐month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2431, doi. 10.1111/dom.15562
- By:
- Publication type:
- Article
Comparison of estimated glomerular filtration rate change with sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists among people with diabetes: A propensity‐score matching study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2422, doi. 10.1111/dom.15561
- By:
- Publication type:
- Article
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2390, doi. 10.1111/dom.15554
- By:
- Publication type:
- Article
Maladaptive response following glucose overload in GLUT4‐overexpressing H9C2 cardiomyoblasts.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2379, doi. 10.1111/dom.15553
- By:
- Publication type:
- Article
Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2513, doi. 10.1111/dom.15552
- By:
- Publication type:
- Article
Practical strategies to manage obesity in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2029, doi. 10.1111/dom.15556
- By:
- Publication type:
- Article
Intra‐pancreatic fat is associated with continuous glucose monitoring metrics.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2359, doi. 10.1111/dom.15550
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitor and sodium‐glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high‐fat diet‐fed mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2339, doi. 10.1111/dom.15548
- By:
- Publication type:
- Article
Could poor glycaemic control be a predictor of walking speed decline in older adults? Evidence from the English Longitudinal Study of Ageing.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2349, doi. 10.1111/dom.15549
- By:
- Publication type:
- Article
Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2329, doi. 10.1111/dom.15547
- By:
- Publication type:
- Article
The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2318, doi. 10.1111/dom.15546
- By:
- Publication type:
- Article
Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2509, doi. 10.1111/dom.15545
- By:
- Publication type:
- Article
Hydrogel dressings for diabetic foot ulcer: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2305, doi. 10.1111/dom.15544
- By:
- Publication type:
- Article
Efficacy of topiramate in reducing second‐generation antipsychotic‐associated weight gain among children: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2292, doi. 10.1111/dom.15543
- By:
- Publication type:
- Article
Analyses of potential causal contributors to increased waist/hip ratio‐associated cardiometabolic disease: A combined and sex‐stratified Mendelian randomization study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2284, doi. 10.1111/dom.15542
- By:
- Publication type:
- Article
Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2275, doi. 10.1111/dom.15541
- By:
- Publication type:
- Article
Effects of home‐based exergaming on cardio‐metabolic and cognitive health in physically inactive individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2267, doi. 10.1111/dom.15540
- By:
- Publication type:
- Article
The GPR40 novel agonist SZZ15‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2257, doi. 10.1111/dom.15539
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and mental health: A meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2505, doi. 10.1111/dom.15538
- By:
- Publication type:
- Article
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2017, doi. 10.1111/dom.15533
- By:
- Publication type:
- Article
Performance of new and panel CKD‐EPI equations in European adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2501, doi. 10.1111/dom.15536
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2209, doi. 10.1111/dom.15529
- By:
- Publication type:
- Article
Ingesting probiotic yogurt containing Lactiplantibacillus plantarum OLL2712 improves glycaemic control in adults with prediabetes in a randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2239, doi. 10.1111/dom.15534
- By:
- Publication type:
- Article
A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2248, doi. 10.1111/dom.15537
- By:
- Publication type:
- Article
Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2492, doi. 10.1111/dom.15532
- By:
- Publication type:
- Article
Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2229, doi. 10.1111/dom.15531
- By:
- Publication type:
- Article
Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2497, doi. 10.1111/dom.15535
- By:
- Publication type:
- Article
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2188, doi. 10.1111/dom.15526
- By:
- Publication type:
- Article
Associations of diabesity with all‐cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2199, doi. 10.1111/dom.15528
- By:
- Publication type:
- Article
Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2176, doi. 10.1111/dom.15525
- By:
- Publication type:
- Article
The role of glucagon‐like peptide‐1 receptor agonists in metabolic dysfunction‐associated steatohepatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2001, doi. 10.1111/dom.15524
- By:
- Publication type:
- Article
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2167, doi. 10.1111/dom.15523
- By:
- Publication type:
- Article
Accelerated onset of diabetes in non‐obese diabetic mice fed a refined high‐fat diet.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2158, doi. 10.1111/dom.15522
- By:
- Publication type:
- Article
Testosterone therapy reduces insulin resistance in men with adult‐onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open‐label phase.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2147, doi. 10.1111/dom.15520
- By:
- Publication type:
- Article
Pharmacological treatment of obesity in adults in Norway 2004–2022.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2102, doi. 10.1111/dom.15515
- By:
- Publication type:
- Article
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2128, doi. 10.1111/dom.15518
- By:
- Publication type:
- Article